A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Gynecological Cancers Research/Clinical Trials Bookmark and Share

Gynecologic Cancers Clinical Trials and Research

In City of Hope’s Gynecologic Oncology Program, physicians collaborate extensively with laboratory scientists to develop and evaluate new therapies designed to treat gynecologic cancers and improve the likelihood of cure. Many of these new treatment approaches are only available at City of Hope. As a patient here, you may qualify to participate in a clinical trial of one of these new therapies. We offer access to a wide variety of clinical trials, including new chemotherapy and targeted therapies, hormone therapies, and surgical approaches to treating gynecologic cancers.
 
 
We are also deeply invested in research to better understand gynecologic cancers, the well-being of patients, and the needs of patients and their family members.
 
Some of the research questions we strive to answer include:
  • Why is there often a rapid and diffuse spreading of cancers from primary gynecologic malignancy sites?
  • Why are some cancers resistant to chemotherapy?
  • What are the potential long-term side effects for cancer survivors and how can we prevent or minimize them?
  • How can treatment of sexual dysfunction be addressed both physically and psychologically?
  • How can the use of psychotherapeutic interventions play a larger role in helping women cope emotionally during and after treatment?
 
Some of our most exciting current research projects include:
 
  • Evaluating expression patterns of genes and potential protein targets from individual patient’s cancer stem cells.
  • Characterizing circulating tumor cells in patients with locally advanced and metastatic disease.
  • Decoding mechanisms of resistance to therapeutic agents.
  • Identifying and interfering with unfavorable activations of genes and transcriptional and signal transduction pathways by studying microRNAs and a host of epigenetic modulatory components.
  • Developing novel therapeutics to treat metastasis.
  • Studying the role of STAT3, a protein highly activated in cancer cells, and developing drugs that block the tumor-regulating protein.
  • Examining the role of PARP inhibitors, a class of drugs that block a cancer cell’s ability to repair DNA damage caused by chemotherapy and radiation therapies. These drugs could make those treatments more effective.
  • Studying a modified version of a PET scan that utilizes a special imaging agent to identify cervical cancer.
  •  Improving counseling and other support services for women at high risk of developing cancer who make the difficult decision to undergo preventative oophorectomies.
  • Developing educational programs focused on the impact of HPV vaccination to reduce the risk of cervical cancer.
  • Studying survivorship with a focus on quality-of-life issues, prevention of secondary cancers, and other survivorship issues.
  • Determining the role of diet and exercise in preventing the recurrence of ovarian cancer.
  •  Evaluating ways to decrease long-term side effects of gynecologic surgery.

Gynecological Cancers Research/Clinical Trials

Gynecologic Cancers Clinical Trials and Research

In City of Hope’s Gynecologic Oncology Program, physicians collaborate extensively with laboratory scientists to develop and evaluate new therapies designed to treat gynecologic cancers and improve the likelihood of cure. Many of these new treatment approaches are only available at City of Hope. As a patient here, you may qualify to participate in a clinical trial of one of these new therapies. We offer access to a wide variety of clinical trials, including new chemotherapy and targeted therapies, hormone therapies, and surgical approaches to treating gynecologic cancers.
 
 
We are also deeply invested in research to better understand gynecologic cancers, the well-being of patients, and the needs of patients and their family members.
 
Some of the research questions we strive to answer include:
  • Why is there often a rapid and diffuse spreading of cancers from primary gynecologic malignancy sites?
  • Why are some cancers resistant to chemotherapy?
  • What are the potential long-term side effects for cancer survivors and how can we prevent or minimize them?
  • How can treatment of sexual dysfunction be addressed both physically and psychologically?
  • How can the use of psychotherapeutic interventions play a larger role in helping women cope emotionally during and after treatment?
 
Some of our most exciting current research projects include:
 
  • Evaluating expression patterns of genes and potential protein targets from individual patient’s cancer stem cells.
  • Characterizing circulating tumor cells in patients with locally advanced and metastatic disease.
  • Decoding mechanisms of resistance to therapeutic agents.
  • Identifying and interfering with unfavorable activations of genes and transcriptional and signal transduction pathways by studying microRNAs and a host of epigenetic modulatory components.
  • Developing novel therapeutics to treat metastasis.
  • Studying the role of STAT3, a protein highly activated in cancer cells, and developing drugs that block the tumor-regulating protein.
  • Examining the role of PARP inhibitors, a class of drugs that block a cancer cell’s ability to repair DNA damage caused by chemotherapy and radiation therapies. These drugs could make those treatments more effective.
  • Studying a modified version of a PET scan that utilizes a special imaging agent to identify cervical cancer.
  •  Improving counseling and other support services for women at high risk of developing cancer who make the difficult decision to undergo preventative oophorectomies.
  • Developing educational programs focused on the impact of HPV vaccination to reduce the risk of cervical cancer.
  • Studying survivorship with a focus on quality-of-life issues, prevention of secondary cancers, and other survivorship issues.
  • Determining the role of diet and exercise in preventing the recurrence of ovarian cancer.
  •  Evaluating ways to decrease long-term side effects of gynecologic surgery.
Quick Links
Gynecological Cancers News
Cooper Finkel Women’s Health Center
Many gynecological cancer and breast cancer  services at City of Hope are provided at the Rita Cooper Finkel and J. William Finkel Women's Health Center. Here, women receive the highest quality care, whether seeking prevention and screening services or coping with a cancer diagnosis.
Tips, tools and resources to help you and your family cope with the issues that arise during and after cancer treatment.
As an leader in cancer research, our goal is to bring the latest scientific findings into medical practice as quickly as possible.
Medical Minute
Listen to the Medical Minute Gynecological Cancers with
Dr. Robert J. Morgan, co-director of the City of Hope gynecological cancers program.
 


NEWS & UPDATES
  • No one ever plans to have cancer – and there’s never a good time. For Homa Sadat, her cancer came at a particularly bad time: just one year after losing her father to the pancreatic cancer he had battled for two years. She was working a grueling schedule managing three commercial office buildings. She’d just [&...
  • Patients at City of Hope – most of whom are fighting cancer – rely on more than 37,000 units of blood and platelets each year for their treatment and survival. Every one of those units comes from family, friends or someone who traded an hour or so of their time and a pint of their […]
  • Surgery is vital in the treatment of cancer – it’s used to help diagnose, treat and even prevent the disease – so a new colorectal cancer study linking a decrease in surgeries for advanced cancer to increased survival rates may raise more questions than it answers for some patients. The surgery-and-surviv...
  • Age is the single greatest risk factor overall for cancer; our chances of developing the disease rise steeply after age 50. For geriatric oncology nurse Peggy Burhenn, the meaning is clear: Cancer is primarily a geriatric condition. That’s why she is forging inroads in the care of older adults with cancer. Burh...
  • One of American’s great sportscasters, Stuart Scott, passed away from recurrent cancer of the appendix at the young age of 49. His cancer was diagnosed when he was only 40 years old. It was found during an operation for appendicitis. His courageous fight against this disease began in 2007, resumed again with an...
  • When Homa Sadat found a lump in her breast at age 27, her gynecologist told her what many doctors say to young women: You’re too young to have breast cancer. With the lump dismissed as a harmless cyst, she didn’t think about it again until she was at a restaurant six months later and felt […]
  • What most people call a “bone marrow transplant” is not actually a transplant of bone marrow; it is instead the transplantation of what’s known as hematopoietic stem cells. Such cells are often taken from bone marrow, but not always. Hematopoietic stem cells are simply immature cells that can ...
  • Doctors have long known that women with a precancerous condition called atypical hyperplasia have an elevated risk of breast cancer. Now a new study has found that the risk is more serious than previously thought. Hyperplasia itself is an overgrowth of cells; atypical hyperplasia is an overgrowth in a distorted...
  • Don’t kid yourself. Just because it’s mid-January doesn’t mean it’s too late to make resolutions for a happier, and healthier, 2015. Just consider them resolutions that are more mature than those giddy, sometimes self-deluded, Jan. 1 resolutions. To that end, we share some advice from Cary A. Presant, M.D., an ...
  • Sales and marketing executive Jim Murphy first came to City of Hope in 2002 to donate blood for a friend who was being treated for esophageal cancer. The disease is serious. Although esophageal cancer accounts for only about 1 percent of cancer diagnoses in the U.S., only about 20 percent of patients survive at...
  • Aaron Bomar and his family were celebrating his daughter’s 33rd birthday in September 2014 when he received alarming news: According to an X-ray taken earlier that day at an urgent care facility, he had a node on his aorta and was in danger of an aneurysm. Bomar held hands with his wife and daughter and s...
  • Explaining a prostate cancer diagnosis to a young child can be difficult — especially when the cancer is incurable. But conveying the need for prostate cancer research, as it turns out, is easily done. And that leads to action. Earlier this year, Gerald Rustad, 71, who is living with a very aggressive form of m...
  • Cancer and its treatment can create unexpected daily challenges for patients. Side effects from chemotherapy, surgery and radiation therapy as well as the disease itself can cause difficulty in everything from speech to movement to eating. When this happens, rehabilitation is vital; it helps patients restore th...
  • Betsy Sauer and her four daughters share plenty in common. They’re smart and successful.  They’re funny, ranging from wryly witty to wickedly hilarious. Their hobbies tend toward the active and adventurous: hiking, rock climbing, skiing, swimming, fishing, kayaking, yoga and horseback riding. Also, they take he...
  • Flu season is upon us, and few people should take the risk of infection more seriously than cancer patients and their loved ones and caregivers. With the federal Centers for Disease Control and Prevention warning of widespread influenza outbreaks, it’s clear that flu season – and the associated risks – won’t en...